Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
| Name | Authors | DOI | Group |
Summary |
Associated Publications |
RRIDs used | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
COVID Blood Processing for scRNAseq Resource Report Resource Website |
Peter Szabo, Steven Wells, Peter A. Sims, Donna Farber | DOI:10.17504/protocols.io.bjm6kk9e | Human Cell Atlas Method Development Community, Coronavirus Method Development Community | This protocol describes the isolation of lymphocytes and pan-mononuclear cells from human whole blood for scRNAseq analysis. | Columbia University, Columbia University, Columbia University, Columbia University | 1 | 2020 | Peter Szabo, Steven Wells, Peter A. Sims, Donna Farber 2020. COVID Blood Processing for scRNAseq. protocols.io https://dx.doi.org/10.17504/protocols.io.bjm6kk9e | 2021-04-15 09:17:02 | |||
|
Amplicon clean-up using SPRI beads Resource Report Resource Website |
Muhammad Faisal, Olin Silander, Nikki Freed | DOI:10.17504/protocols.io.bfwpjpdn | Coronavirus Method Development Community | Massey University, Massey University, Massey University | 1 | 2020 | Muhammad Faisal, Olin Silander, Nikki Freed 2020. Amplicon clean-up using SPRI beads. protocols.io https://dx.doi.org/10.17504/protocols.io.bfwpjpdn | 2021-04-15 09:17:04 | ||||
|
Pooled sample testing (VTM/UTM) for SARS-CoV-2 using Magnetic Nanotrap® particles for direct RNA extraction. Resource Report Resource Website |
Anurag Patnaik, Ben Lepene, Robert Barclay | Coronavirus Method Development Community, Nanotrap Applications | Ceres Nanosciences, inc., Ceres Nanosciences, inc., Ceres Nanosciences, inc. | 1 | 2020 | Anurag Patnaik, Ben Lepene, Robert Barclay 2020. Pooled sample testing (VTM/UTM) for SARS-CoV-2 using Magnetic Nanotrap® particles for direct RNA extraction.. protocols.io https:// | 2021-04-15 09:17:06 | |||||
|
Study Design (Part 3 of Phase 3 study of Vaccine Candidate for COVID-19) Resource Report Resource Website |
Chris Ockenhouse, Chris Gast, Renee Holt, Jorge Flores | DOI:10.17504/protocols.io.bj5wkq7e | Coronavirus Method Development Community | This is Part 3 of "Phase 3 randomized, double-blinded, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of Vaccine Candidate against COVID-19 in adults > 18 years of age"This generic Phase 3 protocol was developed by the PATH team with support of the Bill and Melinda Gates Foundation. The aim of the collection is to share recommended best practices in designing and implementing a Phase 3 study of a COVID-19 vaccine candidate. As Phase 3 trials of different Vaccine Candidates proceed around the world, following the same protocols will ensure consistency and comparability of the Phase 3 trial results.Please note that this is an evolving document, to be versioned and updated, based on community feedback and new data. | Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington) | 1 | 2020 | Chris Ockenhouse, Chris Gast, Renee Holt, Jorge Flores 2020. Study Design (Part 3 of Phase 3 study of Vaccine Candidate for COVID-19). protocols.io https://dx.doi.org/10.17504/protocols.io.bj5wkq7e | 2021-04-15 09:17:07 | |||
|
Safety Assessment and Reporting (Part 7 of Phase 3 study of Vaccine Candidate for COVID-19) Resource Report Resource Website |
Chris Ockenhouse, Chris Gast, Renee Holt, Jorge Flores | DOI:10.17504/protocols.io.bj52kq8e | Coronavirus Method Development Community, PATH | This is Part 7 of "Phase 3 randomized, double-blinded, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of Vaccine Candidate against COVID-19 in adults > 18 years of age"This generic Phase 3 protocol was developed by the PATH team with support of the Bill and Melinda Gates Foundation. The aim of the collection is to share recommended best practices in designing and implementing a Phase 3 study of a COVID-19 vaccine candidate. As Phase 3 trials of different Vaccine Candidates proceed around the world, following the same protocols will ensure consistency and comparability of the Phase 3 trial results.Please note that this is an evolving document, to be versioned and updated, based on community feedback and new data. | Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington), Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington) | 1 | 2020 | Chris Ockenhouse, Chris Gast, Renee Holt, Jorge Flores 2020. Safety Assessment and Reporting (Part 7 of Phase 3 study of Vaccine Candidate for COVID-19). protocols.io https://dx.doi.org/10.17504/protocols.io.bj52kq8e | 2021-04-15 09:17:10 | |||
|
Viral Sequencing, from Gunk to Graph (Two-step, strand-switching) Resource Report Resource Website |
David Eccles | DOI:10.17504/protocols.io.bebujanw | Coronavirus Method Development Community | This is a fast "gunk to graph" protocol for analysing viral RNA from nasopharyngeal swabs. The approach involves swab lysis and inactivation at the point of sampling, uses a cellulose binding / wash protocol to reduce extraction cost, incorporates sample-specific barcodes during first-strand synthesis, nanopore rapid-attachment primers during PCR amplification, and nanopore sequencing with parallel RAMPART analysis for fast assembly and phylogenetics.An alternative protocol using both forward and reverse primers can be found here. | Malaghan Institute of Medical Research (NZ) | 3 | 2020 | David Eccles 2020. Viral Sequencing, from Gunk to Graph (Two-step, strand-switching). protocols.io https://dx.doi.org/10.17504/protocols.io.bebujanw | 2021-04-15 09:17:08 |
Can't find your Protocol?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific protocol and you know the DOI of the protocol already, it's easier to enter a DOI to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your protocol in the search results, please help us by adding it into the system — it's easy. Create and publish your protocols at Protocols.io.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
